The United States Albinism Drug Market holds a significant position in the global rare disease therapeutics industry, supported by advanced healthcare infrastructure, strong biotechnology research capabilities, and favorable regulatory incentives for orphan drug development. The United States Food and Drug Administration continues to encourage innovation through orphan drug designation...